LABU Fact Sheet: Direxion Daily S&P Biotech Bull 3X ETF
Share
$214.83
close, Nov 13, 2026
Over the year to Nov 13, 2026, LABU returned +70.3% in total and charged 0.96% a year.
- 1-year total return
- +70.3%
- XBI +35.1% to Nov 13, 2026
- Expense ratio
- 0.96%
- a year
- Net assets
- $540m
- on Nov 12, 2026
- Net flow, last 5 trading days
- −$787k
- daily basis to Nov 12, 2026
Growth of $10,000, 1 year
LABU $17,034 +70.3% · XBI $13,509 +35.1% · Total return, distributions reinvested, Nov 13, 2025 to Nov 13, 2026.
Returns
WindowTotal return
1 month+2.3%
3 months−22.3%
Year to date+34.8%
1 year+70.3%
3 years+238.0%
Total return, distributions reinvested, each window to Nov 13, 2026.
Facts
Aims to return three times the daily move of biotech (XBI) · First traded May 28, 2015 · Benchmark XBI